Literature DB >> 11809888

The high binding affinity of phosphorothioate-modified oligomers for Ff gene 5 protein is moderated by the addition of C-5 propyne or 2'-O-methyl modifications.

Tung-Chung Mou1, Donald M Gray.   

Abstract

One of the problems that hamper the use of antisense DNAs as effective drugs is the non-specific binding of chemically-modified oligonucleotides to cellular proteins. We previously showed that the affinity of a model ssDNA-binding protein, the Ff gene 5 protein (g5p), was >300-fold higher for phosphorothioate-modified DNA (S-DNA) than for unmodified dA(36), consistent with the propensity of S-DNA to bind indiscriminately to proteins. The current work shows that g5p binding is also sensitive to sugar and pyrimidine modifications used in antisense oligomers. Binding affinities of g5p for 10 36mer oligomers were quantitated using solution circular dichroism measurements. The oligomers contained C-5-propyne (prC), 2'-O-methyl (2'-O-Me) or 2'-OH (RNA) groups, alone or combined with the phosphorothioate modification. In agreement with reported increases in antisense activity, the addition of prC or 2'-O-Me modifications substantially reduced the affinity of oligomers for g5p by approximately 2-fold compared with the same DNA oligomer sequences containing only phosphorothioate linkages. That is, such modifications moderated the propensity of the phosphorothioate group to bind tightly to the g5p. The Ff g5p could be a useful model protein for assessing non-specific binding effects of antisense oligomer modifications.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11809888      PMCID: PMC100283          DOI: 10.1093/nar/30.3.749

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  49 in total

1.  Long-range cooperativity in molecular recognition of RNA by oligodeoxynucleotides with multiple C5-(1-propynyl) pyrimidines.

Authors:  T W Barnes; D H Turner
Journal:  J Am Chem Soc       Date:  2001-05-09       Impact factor: 15.419

2.  Ff gene 5 protein has a high binding affinity for single-stranded phosphorothioate DNA.

Authors:  T C Mou; C W Gray; T C Terwilliger; D M Gray
Journal:  Biochemistry       Date:  2001-02-20       Impact factor: 3.162

Review 3.  Phosphorothioate oligodeoxynucleotides: what is their origin and what is unique about them?

Authors:  F Eckstein
Journal:  Antisense Nucleic Acid Drug Dev       Date:  2000-04

4.  Electrostatic potential distribution of the gene V protein from Ff phage facilitates cooperative DNA binding: a model of the GVP-ssDNA complex.

Authors:  Y Guan; H Zhang; A H Wang
Journal:  Protein Sci       Date:  1995-02       Impact factor: 6.725

5.  Structures of fd gene 5 protein.nucleic acid complexes: a combined solution scattering and electron microscopy study.

Authors:  G A Olah; D M Gray; C W Gray; D L Kergil; T R Sosnick; B L Mark; M R Vaughan; J Trewhella
Journal:  J Mol Biol       Date:  1995-06-09       Impact factor: 5.469

6.  Effect of 2'-O-methyl antisense ORNs on expression of thymidylate synthase in human colon cancer RKO cells.

Authors:  J C Schmitz; D Yu; S Agrawal; E Chu
Journal:  Nucleic Acids Res       Date:  2001-01-15       Impact factor: 16.971

7.  Cellular proteins prevent antisense phosphorothioate oligonucleotide (SdT18) to target sense RNA (rA18): development of a new in vitro assay.

Authors:  I Brukner; G A Tremblay
Journal:  Biochemistry       Date:  2000-09-19       Impact factor: 3.162

8.  Characterization of fully 2'-modified oligoribonucleotide hetero- and homoduplex hybridization and nuclease sensitivity.

Authors:  L L Cummins; S R Owens; L M Risen; E A Lesnik; S M Freier; D McGee; C J Guinosso; P D Cook
Journal:  Nucleic Acids Res       Date:  1995-06-11       Impact factor: 16.971

9.  Inhibition of high affinity basic fibroblast growth factor binding by oligonucleotides.

Authors:  S M Fennewald; R F Rando
Journal:  J Biol Chem       Date:  1995-09-15       Impact factor: 5.157

Review 10.  Antisense approaches to cancer gene therapy.

Authors:  D Mercola; J S Cohen
Journal:  Cancer Gene Ther       Date:  1995-03       Impact factor: 5.987

View more
  6 in total

1.  Lipid Nanoparticles Loaded with an Antisense Oligonucleotide Gapmer Against Bcl-2 for Treatment of Lung Cancer.

Authors:  Xinwei Cheng; Qibing Liu; Hong Li; Chen Kang; Yang Liu; Tianqi Guo; Ke Shang; Chengyun Yan; Guang Cheng; Robert J Lee
Journal:  Pharm Res       Date:  2016-11-28       Impact factor: 4.200

2.  Antisense DNA parameters derived from next-nearest-neighbor analysis of experimental data.

Authors:  Donald M Gray; Carla W Gray; Byong-Hoon Yoo; Tzu-Fang Lou
Journal:  BMC Bioinformatics       Date:  2010-05-14       Impact factor: 3.169

3.  2'-O-methyl-modified phosphorothioate antisense oligonucleotides have reduced non-specific effects in vitro.

Authors:  Byong Hoon Yoo; Elena Bochkareva; Alexey Bochkarev; Tung-Chung Mou; Donald M Gray
Journal:  Nucleic Acids Res       Date:  2004-04-02       Impact factor: 16.971

4.  Cellular uptake mediated by epidermal growth factor receptor facilitates the intracellular activity of phosphorothioate-modified antisense oligonucleotides.

Authors:  Shiyu Wang; Nickolas Allen; Timothy A Vickers; Alexey S Revenko; Hong Sun; Xue-Hai Liang; Stanley T Crooke
Journal:  Nucleic Acids Res       Date:  2018-04-20       Impact factor: 16.971

5.  Mechanism of Mitochondrial Transcription Factor A Attenuation of CpG-Induced Antibody Production.

Authors:  Christopher S Malarkey; Claire E Gustafson; Jessica F Saifee; Raul M Torres; Mair E A Churchill; Edward N Janoff
Journal:  PLoS One       Date:  2016-06-09       Impact factor: 3.240

6.  Enhanced affinity of racemic phosphorothioate DNA with transcription factor SATB1 arising from diastereomer-specific hydrogen bonds and hydrophobic contacts.

Authors:  Kazuhiko Yamasaki; Yukie Akutsu; Tomoko Yamasaki; Makoto Miyagishi; Tomomi Kubota
Journal:  Nucleic Acids Res       Date:  2020-05-07       Impact factor: 16.971

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.